{"id":"W2151119213","doi":"10.1158/1078-0432.ccr-07-1223","title":"Pretargeted Radioimmunotherapy for B-Cell Lymphomas","year":2007,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Radioimmunotherapy; Medicine; Lymphoma; Monoclonal antibody; Pretargeting; Cancer research; Oncology; Refractory (planetary science); Internal medicine; Immunology; Antibody; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004275985,0.0003516081,0.002043758,0.0001585867,0.0002132536,0.0000402579,0.0005138483,0.0009644885,0.001073379],"category_scores_gemma":[0.0006404851,0.0002691635,0.001347155,0.0008557087,0.00066785,0.00002641943,0.00008028151,0.002212846,0.0001947659],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004745423,"about_ca_system_score_gemma":0.002408048,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001121476,"about_ca_topic_score_gemma":5.832156e-7,"domain_scores_codex":[0.9958513,0.0002874605,0.001422627,0.0009076748,0.0006600419,0.0008709436],"domain_scores_gemma":[0.9931051,0.004601595,0.0002017124,0.0009704315,0.0004772161,0.0006439242],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003548072,0.0006286243,0.0000117718,0.02139401,0.0002806424,0.00001892326,0.000005357774,4.553927e-8,0.00002047613,0.0000878447,0.01969604,0.9575015],"study_design_scores_gemma":[0.002388173,0.0002744737,0.000005002538,0.003664999,0.0005727608,0.0000231386,0.000003792962,0.00001846743,0.0001850483,0.00007707554,0.9925377,0.000249381],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002431433,0.988811,0.0001111575,0.0003953175,0.0002327158,0.00388535,0.0001573185,0.00007116893,0.006311723],"genre_scores_gemma":[0.00001704452,0.9778206,0.000623434,0.000286748,0.002660822,0.002744336,0.0002529843,0.0001247464,0.01546922],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9728416,"threshold_uncertainty_score":0.999976,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.7771471648139743,"score_gpt":0.7280431915978613,"score_spread":0.04910397321611293,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}